View in EDS

Open-label, randomized study of individualized, pharmacokinetically (PK)-guided dosing of paclitaxel combined with carboplatin or cisplatin in patients with advanced non-small-cell lung cancer (NSCLC).

Saved in:
Bibliographic Details
Title: Open-label, randomized study of individualized, pharmacokinetically (PK)-guided dosing of paclitaxel combined with carboplatin or cisplatin in patients with advanced non-small-cell lung cancer (NSCLC).
Authors: Joerger M; Department of Medical Oncology, Cantonal Hospital, St Gallen, Switzerland markus.joerger@kssg.ch., von Pawel J; Pneumology Clinic, Asklepios Fachkliniken, Gauting., Kraff S; Institute of Pharmacy, Clinical Pharmacy, University of Bonn, Bonn., Fischer JR; Department of Medical Oncology, Klinik Löwenstein, Löwenstein., Eberhardt W; Department of Medical Oncology, West German Cancer Center, University Hospital Essen, Essen., Gauler TC; Department of Medical Oncology (Cancer Research), West German Cancer Center, University Hospital Essen of University Duisburg-Essen, Essen., Mueller L; Oncological Practice, Praxis Leer, Leer., Reinmuth N; Lung Clinic Grosshansdorf, Airway Research Center North (ARCN), Member of the German Center for Lung Research (DZL), Grosshansdorf., Reck M; Lung Clinic Grosshansdorf, Airway Research Center North (ARCN), Member of the German Center for Lung Research (DZL), Grosshansdorf., Kimmich M; Pulmonology and Oncology, Klinik Schillerhöhe, Gerlingen., Mayer F; Department of Oncology and Hematology, University Hospital, Medical Center II, Tübingen., Kopp HG; Department of Oncology and Hematology, Eberhard Karls University Medical Center, Tübingen., Behringer DM; Medical Oncology, Augusta-Kranken-Anstalt, Bochum., Ko YD; Medical Oncology, Johanniter-Krankenhaus Bonn, Bonn., Hilger RA; Cancer Research, University Hospital Essen, Essen, Germany., Roessler M; CESAR Central Office (CCO), Vienna CESAR Central European Society for Anticancer Drug Research-EWIV, Vienna, Austria., Kloft C; Department of Clinical Pharmacy and Biochemistry, Institute of Pharmacy, Free University Berlin, Berlin, Germany., Henrich A; Department of Clinical Pharmacy and Biochemistry, Institute of Pharmacy, Free University Berlin, Berlin, Germany., Moritz B; CESAR Central Office (CCO), Vienna CESAR Central European Society for Anticancer Drug Research-EWIV, Vienna, Austria., Miller MC; Saladax Biomedical, Inc., Bethlehem, USA., Salamone SJ; Saladax Biomedical, Inc., Bethlehem, USA., Jaehde U; Institute of Pharmacy, Clinical Pharmacy, University of Bonn, Bonn.
Source: Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2016 Oct; Vol. 27 (10), pp. 1895-902. Date of Electronic Publication: 2016 Aug 08.
Publication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1569-8041
DOI:10.1093/annonc/mdw290